Page last updated: 2024-09-04

moxifloxacin and Familial Mediterranean Fever

moxifloxacin has been researched along with Familial Mediterranean Fever in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Drewe, E; McDermott, EM; Powell, RJ	1

Other Studies

1 other study(ies) available for moxifloxacin and Familial Mediterranean Fever

Article	Year
Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology (Oxford, England), 2007, Volume: 46, Issue:12 Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aza Compounds; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Etanercept; Familial Mediterranean Fever; Female; Fluoroquinolones; Follow-Up Studies; Humans; Immunoglobulin G; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome	2007

Article

Year

Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

Rheumatology (Oxford, England), 2007, Volume: 46, Issue:12

Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aza Compounds; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Etanercept; Familial Mediterranean Fever; Female; Fluoroquinolones; Follow-Up Studies; Humans; Immunoglobulin G; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome

2007